Bérangère S. Joly

Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19

Bérangère S. Joly, Virginie Siguret, Agnès Veyradier · Intensive Care Medicine · 2020 · 215 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +14

An open conformation of ADAMTS‐13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura

Elien Roose, An‐Sofie Schelpe, Bérangère S. Joly et al. · Journal of Thrombosis and Haemostasis · 2017 · 91 citations · Full text

Medicine, Biochemistry, Molecular Biology +8

Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy

Bérangère S. Joly, Alain Stépanian, Thierry Leblanc et al. · The Lancet Haematology · 2016 · 80 citations

Medicine, Hematology, Pediatrics +13

Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura

Elien Roose, An‐Sofie Schelpe, Edwige Tellier et al. · Blood · 2020 · 74 citations · Full text

Medicine, Hematology, Pathology +11

ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw–Schulman Syndrome

Bérangère S. Joly, Pierre Boisseau, Elien Roose et al. · Thrombosis and Haemostasis · 2018 · 67 citations · Full text

Life Sciences, Genetics, Hematology +5